NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Great article RRH except for the writer's opinion that MHRA's
approval will be greatly delayed (late 2025 or early 2026).
I would very much like to understand the rationale for that opinion.

The only reason I can come up with is MHRA's possible insistence
for an extremely robust Flaskworks manufacturing capacity and that
would cause a major approval delay and would also eliminate the
possibility that NWBO will start off with the artisan production
method.

If this delay is real, wouldn't that be a material event especially since
LP indicated that the artisan method will be initially used after approval?
If so, this should merit an update from the company.